Based on the Genmab AS stock forecast from 4 analysts, the average analyst target price for Genmab AS is USD 45.44 over the next 12 months. Genmab AS’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Genmab AS is Slightly Bullish , which is based on 2 positive signals and 1 negative signals. At the last closing, Genmab AS’s stock price was USD 20.47. Genmab AS’s stock price has changed by +2.20% over the past week, -0.87% over the past month and -34.89% over the last year.
No recent analyst target price found for Genmab AS
No recent average analyst rating found for Genmab AS
Company Overview Genmab AS
N/A
N/A
N/A
N/A
USD
USA
Adjusted Closing Price for Genmab AS (GMAB)
Loading...
Unadjusted Closing Price for Genmab AS (GMAB)
Loading...
Share Trading Volume for Genmab AS Shares
Loading...
Compare Performance of Genmab AS Shares
Symbol
Capital Gain
Dividend Return
Total Return
Loading...
Loading...
Technical Indicators for GMAB
Assets
Top Holdings
N/A
Top Sectors
Top Regions
Stocks Similar To Genmab AS (Sector: Biotechnology )
Frequently Asked Questions About Genmab AS (GMAB) Stock
Based on ratings from 4 analysts Genmab AS's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 7 buy, sell and 2 hold ratings.
Unfortunately we do not have enough data on GMAB's stock to indicate if its a good dividend stock.
Based on targets from 4 analysts, the average taret price for GMAB is USD 45.44 over the next 12 months. The maximum analyst target price is USD 50 while the minimum anlayst target price is USD 31.
Unfortunately we do not have enough data on GMAB's stock to indicate if its overvalued.
The last closing price of GMAB's stock was USD 20.47.
Unfortunately we do not currently have any market capitalization data for GMAB's stock.
Based on targets from 4 analysts, the average taret price for GMAB is projected at USD 45.44 over the next 12 months.
This means that GMAB's stock price may go up by +122.01% over the next 12 months.
We can't find any ETFs which contains Genmab AS's stock.
Sorry, we do not have any data on the number of employees for Genmab AS.
Sorry we do not have any infomation available on Genmab AS's address.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior Earnings Growth
This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.
What not to like
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Frequently Asked Questions About Genmab AS (GMAB) Stock
Based on ratings from 4 analysts Genmab AS's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bullish . The stock has 7 buy, sell and 2 hold ratings.
Unfortunately we do not have enough data on GMAB's stock to indicate if its a good dividend stock.
Based on targets from 4 analysts, the average taret price for GMAB is USD 45.44 over the next 12 months. The maximum analyst target price is USD 50 while the minimum anlayst target price is USD 31.
Unfortunately we do not have enough data on GMAB's stock to indicate if its overvalued.
The last closing price of GMAB's stock was USD 20.47.
Unfortunately we do not currently have any market capitalization data for GMAB's stock.
Based on targets from 4 analysts, the average taret price for GMAB is projected at USD 45.44 over the next 12 months.
This means that GMAB's stock price may go up by +122.01% over the next 12 months.
We can't find any ETFs which contains Genmab AS's stock.
Sorry, we do not have any data on the number of employees for Genmab AS.
Sorry we do not have any infomation available on Genmab AS's address.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for GMAB !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
